At Malladi Bariatrics and Advanced Surgery, staying up to date on the latest research is part of how we take care of our patients. We work with individuals and families at our Plano and Dallas offices, and we believe clear, honest information matters just as much as the treatments we offer.
GLP-1 medications like semaglutide and tirzepatide have already changed how we treat weight loss and metabolic health. Now, early research is pointing to something interesting. These medications may also help reduce cravings linked to addiction.
It is still early, and there is more to learn, but the findings so far are worth paying attention to.
How GLP-1 Medications Work in the Brain
GLP-1 drugs were originally created to treat type 2 diabetes. Their ability to reduce appetite came later, and that is what made medications like Ozempic, Wegovy, and Mounjaro so widely known.
What is getting attention now is how these medications affect the brain. They interact with the same reward and dopamine systems that drive cravings, not just for food, but also for things like alcohol, nicotine, and other substances.
In simple terms, they may help “quiet” the part of the brain that makes cravings feel intense and hard to ignore. That is why researchers are starting to explore their role beyond weight loss.
What the Research Is Showing So Far
The research is still developing, but early results across different types of addiction are promising.
- Alcohol: A recent clinical trial found that people taking low-dose semaglutide had fewer cravings and drank less compared to those on a placebo.
- Opioids: Some studies suggest lower overdose rates and reduced cravings in patients using GLP-1 medications.
- Nicotine: Early data shows these medications may help reduce smoking, while also helping prevent the weight gain that often comes with quitting.
- Overall: A large study involving more than 600,000 U.S. veterans found that GLP-1 use was linked to a lower risk of developing substance use disorders across multiple categories.
What stands out is that these medications may work across different addictions, likely because they target cravings themselves, not just one specific substance.
What This Means for Patients
If you are already taking a GLP-1 medication for weight loss or metabolic health, this research adds another layer to the conversation.
Many people dealing with weight challenges also struggle with things like emotional eating, alcohol use, or smoking. The idea that one treatment could help with both metabolic health and cravings is important.
That said, there are a few things to keep in mind:
- Most studies are still early or observational
- These medications are not FDA-approved for addiction treatment
- They are not right for everyone and can have side effects
- They work best as part of a full care plan, not on their own
The bottom line is this: the early signals are encouraging, but more research is needed.
How Malladi Bariatrics Approaches GLP-1 Therapy
At our practice, we offer both surgical and non-surgical options for weight loss and metabolic health. GLP-1 medications are one of the tools we use for the right patients.
We stay closely aligned with the latest research and make sure every patient understands both the benefits and the limitations. There is no one-size-fits-all approach here.
For patients across Collin County, we focus on personalized care, thoughtful guidance, and long-term support, because that is what leads to real, lasting results.
Curious if GLP-1 Therapy Is Right for You?
The science around GLP-1 medications is moving fast, and it can be hard to keep up. That is where we come in.
If you are interested in weight loss, improving your metabolic health, or just want to better understand your options, our team is here to help.
Reach out today to schedule a consultation with Dr. Malladi and start a conversation about what might be right for you.